BEAMSTART Logo

Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others

Business Standard LogoBusiness Standard20h ago

Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others - Business Standard

Quick Summary:

The Indian pharmaceutical giants are taking a halt in filing new drug applications, with new filings lowest in the past 19 years, says a latest report by Japanese brokerage firm, Nomura.

The trend of first cycle approvals also seems healthy as in FY24 (Oct-23 to Jun-24) around 18 per cent of the approvals being first-cycle approvals, in line with the 6 year average of 16-18 per cent.

However, the company faces additional competition in gAsacol HD, which represents 8 per cent of its sales, according to IQVIA data for the three months ending July 2024.


More Pictures

Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others - Business Standard (Picture 1)

or

Article Details

Category: BusinessFinance

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-16 @ 11:02:21 (20 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 650 words

Reading Time: 4 minutes read

Sentences: 29 lines

Sentence Length: 23 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 22524118

View Article Analysis

About Business Standard

Business Standard Logo

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 287 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 7 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others" has 650 words across 29 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Which news outlet covered this story?

The story "Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others" was covered 20 hours ago by Business Standard, a news publisher based in India.

How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.

The outlet is headquartered in India and publishes an average of 287 news stories per day.

It's most recent story was published 7 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #22524118
  • URL: https://beamstart.com/news/pharma-stocks-nomura-gives-buy-17264653426632

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.